Five-Year Outcome and Safety in Patients Treated With Immune Checkpoint Blockade Therapies for Urothelial Carcinoma: Experience From Real-World Clinical Practice.
Clin Genitourin Cancer
; 21(3): 334-341, 2023 06.
Article
in En
| MEDLINE
| ID: mdl-36641357
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Urinary Bladder Neoplasms
/
Carcinoma, Transitional Cell
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
Language:
En
Year:
2023
Type:
Article